Aura Biosciences, Inc. (AURA)
NASDAQ: AURA · Real-Time Price · USD
5.59
-0.12 (-2.02%)
Mar 6, 2026, 4:00 PM EST - Market closed
Aura Biosciences Employees
As of December 31, 2024, Aura Biosciences had 109 total employees, including 106 full-time and 3 part-time employees. The number of employees increased by 20 or 22.47% compared to the previous year.
Employees
109
Change (1Y)
20
Growth (1Y)
22.47%
Revenue / Employee
n/a
Profits / Employee
-$976,752
Market Cap
353.71M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 109 | 20 | 22.47% |
| Dec 31, 2023 | 89 | 17 | 23.61% |
| Dec 31, 2022 | 72 | 20 | 38.46% |
| Dec 31, 2021 | 52 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Ginkgo Bioworks Holdings | 834 |
| Bicycle Therapeutics | 305 |
| Absci | 157 |
| Niagen Bioscience | 104 |
| Keros Therapeutics | 82 |
| Armata Pharmaceuticals | 60 |
| PureTech Health | 56 |
| Atea Pharmaceuticals | 56 |
AURA News
- 3 months ago - Aura Biosciences to Participate in the 8th Annual Evercore Healthcare Conference - GlobeNewsWire
- 4 months ago - Aura Biosciences Reports Third Quarter 2025 Financial Results and Business Highlights - GlobeNewsWire
- 6 months ago - Aura Biosciences to Participate in the H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewsWire
- 7 months ago - Aura Biosciences Reports Second Quarter 2025 Financial Results and Business Highlights - GlobeNewsWire
- 10 months ago - Aura Biosciences Announces Pricing of Public Offering of Common Stock and Warrants - GlobeNewsWire
- 10 months ago - Aura Biosciences Announces Proposed Public Offering of Common Stock and Warrants - GlobeNewsWire
- 10 months ago - Aura Biosciences Reports First Quarter 2025 Financial Results and Business Highlights - GlobeNewsWire
- 11 months ago - Aura Biosciences to Participate in Upcoming Investor Conferences - GlobeNewsWire